Mobile Cardiac Telemetry and Advanced Multi-Parameter Monitoring in Patients
NCT ID: NCT04754204
Last Updated: 2022-02-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
585 participants
OBSERVATIONAL
2020-12-15
2021-12-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Mobile Cardiac Telemetry and Advanced Multi-Parameter Monitoring in PatientS Wearing a Novel Device With Biometric Based Medications Changes
NCT05505136
Dynamic Data-Driven Management of Atrial Fibrillation Using Implantable Cardiac Monitors: The MONITOR-AF Study
NCT06352060
Metabolic Mapping and Cardiac Resynchronization
NCT03420833
Clinical Utility and Validation of the Rhythmia Mapping System for the Treatment of Cardiac Arrhythmias
NCT03094221
Optimizing Beta Blocker Dosage in Women While Using the Wearable Cardioverter Defibrillator
NCT04504188
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients indicated for Mobile Cardiac Telemetry Monitoring
Patients indicated for Mobile Cardiac Telemetry Monitoring while meeting inclusion/exclusion criteria and enrolled in sequential manner.
Arrhythmia Management System (AMS)
AMS records rhythm, heart rate, subject-reported symptoms, and multiple parameters that include respiration rate, activity and body posture.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Arrhythmia Management System (AMS)
AMS records rhythm, heart rate, subject-reported symptoms, and multiple parameters that include respiration rate, activity and body posture.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subjects who have an indication for mobile cardiac telemetry (MCT) monitoring
* Subjects 21 years of age or older
Exclusion Criteria
* Subjects with wearable cardioverter defibrillator, Holter monitors, wearable event recorders, and other mobile cardiac telemetry devices at the same time
* Subjects currently hospitalized
* Subjects with a skin condition preventing them from wearing the AMS device
* Subjects who are non-ambulatory
* Subjects who are self-reporting to be pregnant
* Subjects participating in another study
21 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Zoll Medical Corporation
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ramu Perumal, PhD
Role: STUDY_CHAIR
Zoll Services LLC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Comprehensive Cardiovascular Medical Group
Bakersfield, California, United States
Cardiovascular Innovation and Research Center
Long Beach, California, United States
Heartbeat Cardiovascular Medical Group
Los Angeles, California, United States
Interventional Cardiology Group
West Hills, California, United States
Flagler Hospital/Flagler Health
Jacksonville, Florida, United States
Cardiovascular Institute of Central Florida
Ocala, Florida, United States
First Coast Heart and Vascular Center
Saint Augustine, Florida, United States
Cardiovascular Research of Northwest Indiana
Munster, Indiana, United States
Cardiovascular Research of Northwest
Munster, Indiana, United States
Jackson Heart Clinic
Jackson, Mississippi, United States
Trinity Medical
Cheektowaga, New York, United States
PMG Research of Wilmington
Wilmington, North Carolina, United States
Erlanger Health System
Chattanooga, Tennessee, United States
ClinicalTex Research LLC d/b/a PharmaTex Research
Amarillo, Texas, United States
Texas Cardiology Associates of Houston
Kingwood, Texas, United States
Heart Rhythm Specialists
McKinney, Texas, United States
CardioVoyage
McKinney, Texas, United States
Orion Medical Research
Pasadena, Texas, United States
Daniel W. Gottlieb, MD, PS
Burien, Washington, United States
St. Mary's Medical Center
Huntington, West Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
90D0234
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.